Participants in the FORWARD-53 trial had clinically significant improvements in time-to-rise, among other metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback